OpenAlex
PricingAboutJobs
Log inGet started
Work

A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes

HTML

Year: 2012
Type: article
Source: Expert Opinion on Pharmacotherapy
DOI: 10.1517/14656566.2012.692777
Author: Eduard Montanya
Institutions: Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Universitat de Barcelona
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, exenatide twice daily, liraglutide, exenatide extended-release, HbA1c reduction, weight loss, postprandial glucose control, hypoglycemia risk, medication adherence, dosing frequency
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2160442093
FWCI: 3.501
Cites: 92
Cited by: 29
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security